GRADIENT CAPITAL ADVISORS, LLC Regeneron Pharmaceuticals, Inc. Transaction History

GRADIENT CAPITAL ADVISORS, LLC portfolio value:

$265,000
portfolio value

Regeneron Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 384 shares 265K $688.87 384